Skip to content

Differential Diagnosis of STA-PSV in Thyrotoxicosis

Differential Diagnosis Value of Peak Systolic Velocity of Thyroid Superior Artery Using Color Flow Doppler Sonography in Transient Thyrotoxicosis Caused by Thyroiditis and Graves Disease

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01227499
Enrollment
169
Registered
2010-10-25
Start date
2010-06-30
Completion date
2011-11-30
Last updated
2014-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Graves Disease, Peak Systolic Velocity of Superior Thyroid Artery, Thyroiditis, Thyrotoxicosis

Brief summary

Aim: Graves's disease and thyroiditis can both characterized with thyrotoxicosis, but their clinical outcome and therapy is quiet different. Measurement of iodine uptake is the gold standard to differential diagnosis the thyroiditis or Graves's disease. But the iodine uptake is limited for its availability in china and easily influenced by medicine or food contained iodine.The blood pattern of thyroid CFDS is useful for differentiate the cause of thyrotoxicosis.Most previous studies using the descriptive pattern of thyroid CFDS is easily varied by operator subjective judgement. This study is focus on the role of peak systolic velocity of thyroid superior artery in differential diagnosis of thyrotoxicosis. Methods: Patients with thyrotoxicosis symptoms without recent medicine history were enrolled in two clinical center. Its thyroid function, iodine uptake , CFDS of thyroid and peak systolic velocity of thyroid superior artery is detected. Thyrotoxicosis is defined as TSH level below the low value of normal range. Graves disease is defined as the typical symptoms of graves disease such as graves ophthalmopathy or increased iodine uptake. Thyroiditis is defined as lack of typical symptoms of graves disease or decreased iodine uptake.We use receiver operator curve(ROC) to evaluate its diagnosis value

Interventions

None listed

Sponsors

Zhongda Hospital
CollaboratorOTHER
Fudan University
CollaboratorOTHER
xiaolong zhao
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
15 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* newly diagnosed without taking any antithyroid drug or beta receptor blocker with TSH level below the lower limits of reference range * is willing to be enrolled

Exclusion criteria

* unwilling * taking antithyroid drug or beta receptor blocker * taking foods or medicine rich in iodine in 8 weeks * women with pregnant or lactation

Design outcomes

Primary

MeasureTime frameDescription
mean STA-PSV2014-04-07the mean STA-PSV
uptake of iodineDecember 1, 2013

Secondary

MeasureTime frame
PSVDecember 1, 2013

Other

MeasureTime frame
thyroid funcitonDecember 1, 2013

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026